Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
In vitro method for designing a customized therapy for a subject with Parkinson´sDisease CSIC, Université de Lille, INSERM and Centre Hospitalier Regional Universitaire de Lille have developed an in vitro method for designing a customized therapy for a Parkinson ‘s Disease patient through the determination of the presence of a centrosomal deficit from that subject and therefore susceptible to receive a therapy based on a LRRK2 inhibitor. LRRK2 is a key player for the development of both genetic and sporadic forms of Parkinson’s Disease (PD). Industrial partners from pharmaceutical industry are being sought to collaborate through a patent licence agreement.
Yissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew UniversityTechnology Transfer Office
View ProfileYissum - Research Development Company of the Hebrew University posted this:
Superfood for HoneybeesSuperfood for Honeybees Project ID : 24-2017-4416
Yissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew UniversityTechnology Transfer Office
View ProfileYissum - Research Development Company of the Hebrew University posted this:
Diagnosis & Rehabilitation of Language Disorders in Children, Using a Self-Operated Tablet Based AppDiagnosis & Rehabilitation of Language Disorders in Children, Using a Self-Operated Tablet Based App Project ID : 19-2019-8746 Yissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew UniversityTechnology Transfer Office
View ProfileYissum - Research Development Company of the Hebrew University posted this:
Enhanced Secretion of Proteins by Tag-Cleaving Cellular SystemEnhanced Secretion of Proteins by Tag-Cleaving Cellular System Project ID : 6-2019-8747
Ivan Rodriguez RoselloUniversidad de AlicanteIvan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante
University of Vigo posted this:
Valorization of whey and vinasses by producing antimicrobial extracts using biotechnological processesThis invention is based on the production of antimicrobial extracts with potential application against pathogenic microorganisms. The biotechnological production of antimicrobial metabolites was carried out using Lactobacillus plantarum strains. Two industrial wastes, whey, and wine distilled lees (or vinasses) were assayed in order to make the process economically competitive with regard to the chemical one. The extracts are mainly composed by lactic acid, 3-phenyllactic and bacteriocins. Whey was enzymatically hydrolyzed and the solutions were fermented sequentially or simultaneously. The bioprocesses were carried out continuously or discontinuouslyjaume mir posted this:
CEO at Biochemize SL
UACOOPERA University of AveirouacooperaUACOOPERA University of Aveiro posted this:
Technology Transfer Office at uacoopera
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Benzothiazole Derivatives as CK-1 Inhibitors for the Treatment of Amyotrophic Lateral Sclerosis CSIC has synthesized a family of benzothiazoles which acts as casein kinase 1 (CK-1) inhibitors. Therefore, these compounds are useful for the treatment of diseases related to circadian rhythm and neurodegenerative, inflammatory, autoimmune, neurological and psychiatric diseases where CK-1 is relevant. Furthermore, these compounds induce cell regeneration. Pharmaceutical companies interested in a patent licence are sought for.
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Test for oral tolerance to triglycerides in humansThe Instituto de la Grasa of CSIC and University of Seville have developed a fast and simple procedure to evaluate the tolerance to dietary fats (triglycerides) in humans. A novel emulsified composition, easy to take and digest, is supplied to patients, and then the peak of triglycerides in blood and their clearance are determine in a short period of 4 hours. Companies interested in exploiting this technology under a patent license are sought. An offer for patent licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Oleuropein obtaining procedure: high purity antioxidantCSIC has developed a reliable and effective method for obtaining oleuropein from olive leaf: comprising a pretreatment that increases the concentration of oleuropein in the extracts over other known methods and achieving this bioactive compound with a purity superior of 70%. Industrial partners from the food and pharmaceutical industry are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Myt-healer: a new potent wound healing peptideCSIC and the University Miguel Hernández have developed a minimal peptide core from the M yti lus galloprovidencialis Myticin C peptide with unique in vitro and in vivo wound healing and regenerating activities. Industrial partners from the pharmaceutical and cosmetic industry are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Modulating compounds of KChIP2 and its use for the treatment of cardiovascularppaatthhoollooggiieess CSIC and UAM have developed compounds that positively modulate protein-protein interactions that involve KChIP2 protein. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
OPTOBIOTICS: Novel antibacterial proteins activated by blue lightCSIC has developed a chimeric protein that, when expressed in bacteria, changes its structure upon absorption of blue light, thus generating protein aggregates (amyloids) that inhibit bacterial growth Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement An offer for Patent Licensing
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Continuous indoor rearing of Philaenus spumarius, the main European vector of Xylella fastidiosaCSIC has developed a methodology to rear the meadow spittlebug Philaenus spumarius (L.) (Hemiptera, Aphrophoridae) in control climatic conditions in the laboratory allowing the supply of nymphs and adults before they become available in the field. This continuous indoor-rearing protocol could facilitate studies on the biology, ecology and management of P. spumarius and on the transmission of Xylella fastidiosa. Innovative and research partners from the agro sector are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing
